Net Cash Provided by (Used in) Operating Activities |
106M |
USD |
+179% |
Q1 2025 |
Q1 2026 |
Net Cash Provided by (Used in) Financing Activities |
3.33M |
USD |
-34.7% |
Q1 2025 |
Q1 2026 |
Net Cash Provided by (Used in) Investing Activities |
-81.9M |
USD |
-192% |
Q1 2025 |
Q1 2026 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
28.1M |
USD |
-78.8% |
Q1 2025 |
Q1 2026 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
256M |
USD |
-39.2% |
Q1 2025 |
Q1 2026 |
Deferred Tax Assets, Valuation Allowance |
324M |
USD |
-1.42% |
Q4 2024 |
FY 2025 |
Deferred Tax Assets, Gross |
347M |
USD |
+3.51% |
Q4 2024 |
FY 2025 |
Operating Lease, Liability |
300K |
USD |
-40% |
Q1 2025 |
Q1 2026 |
Depreciation |
4.4M |
USD |
+37.5% |
Q4 2023 |
FY 2025 |
Payments to Acquire Property, Plant, and Equipment |
912K |
USD |
+30.3% |
Q1 2025 |
Q1 2026 |
Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
7.98M |
USD |
+46.7% |
Q1 2025 |
Q1 2026 |
Lessee, Operating Lease, Liability, to be Paid |
300K |
USD |
-40% |
Q1 2025 |
Q1 2026 |
Property, Plant and Equipment, Gross |
7.09M |
USD |
-31.4% |
Q4 2024 |
FY 2025 |
Operating Lease, Liability, Current |
275K |
USD |
-32.9% |
Q4 2024 |
FY 2025 |
Operating Lease, Weighted Average Discount Rate, Percent |
0.03 |
pure |
0% |
Q1 2025 |
Q1 2026 |
Deferred Tax Assets, Operating Loss Carryforwards |
92.4M |
USD |
+8.3% |
Q4 2024 |
FY 2025 |
Preferred Stock, Shares Issued |
0 |
shares |
|
Q1 2025 |
Q1 2026 |
Preferred Stock, Shares Authorized |
50M |
shares |
0% |
Q1 2025 |
Q1 2026 |
Unrecognized Tax Benefits |
29.1M |
USD |
-92.7% |
Q1 2025 |
Q1 2026 |
Operating Lease, Payments |
65K |
USD |
-66.7% |
Q1 2025 |
Q1 2026 |
Additional Paid in Capital |
2.01B |
USD |
+13.8% |
Q1 2025 |
Q1 2026 |
Preferred Stock, Shares Outstanding |
0 |
shares |
|
Q1 2025 |
Q1 2026 |
Amortization of Intangible Assets |
9.06M |
USD |
+239% |
Q1 2025 |
Q1 2026 |
Depreciation, Depletion and Amortization |
556K |
USD |
-40.7% |
Q1 2025 |
Q1 2026 |
Deferred Tax Assets, Net of Valuation Allowance |
23.3M |
USD |
+239% |
Q4 2024 |
FY 2025 |
Share-based Payment Arrangement, Expense |
199M |
USD |
+15.3% |
Q1 2025 |
Q1 2026 |
Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q1 2025 |
Q1 2026 |